Article

South China Morning PostSouth China Morning Post on 2022-04-16 16:58

Coronavirus: Hong Kong approves clinical trials for 3 Chinese vaccines targeting Omicron

Sinovac Biotech and China National Biotec Group have received approval to carry out clinical trials in the city for new vaccines.

Related news